glp-1 drug mounjaro Could Weight Loss Drugs Also Treat or Prevent Chronic Diseases? Compare GLP-1 Options | Ozempic
Description
Ongoing pharmacovigilance continues to monitor this safety signal
Most events included nausea, diarrhoea, and vomiting and were mild to moderate
Combination therapy is typically considered for patients with inadequate glycemic control on GLP-1 monotherapy or when cost, adherence, or side effects favor adding an oral DPP-4 rather than increasing GLP-1 dose
Those differences in manufacturing, ingredients and formulations are exactly what has some clinicians worried about their patients use of compounded GLP-1s
doi: 10.1210/en.2009-1197
GLP Review Hub may receive compensation when a visitor purchases through certain links on this page.
